Quality assessment of observational studies in psychiatry: An examplefrom perinatal psychiatric research

International Journal of Methods in Psychiatric Research

Volumn 20, Issue 4, 2011, Pages 224-234

  Ross, L E ^a,b,c   Grigoriadis, S ^b,c,d,e   Mamisashvili, L ^d,e   Koren, G ^c,f,g   Steiner, M ^h,i,j   Dennis, C L ^b,c   Cheung, A ^d   Mousmanis, P ^k  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ MCMASTER UNIVERSITY   (Canada)

^j UNIVERSITY OF TORONTO   (Canada)

^k Professional Development and Practice Support   (Canada)

more..

Author keywords

Antidepressant medication; Depression in pregnancy; Quality assessment

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; COHORT ANALYSIS; EVIDENCE BASED MEDICINE; FACTUAL DATABASE; FEMALE; HUMAN; MALE; MEDICAL RESEARCH; MENTAL DISEASE; METHODOLOGY; OBSERVATION; OUTCOME ASSESSMENT; PREGNANCY; PRENATAL EXPOSURE; STATISTICS;

ANTIDEPRESSIVE AGENTS; BIOMEDICAL RESEARCH; COHORT STUDIES; DATABASES, FACTUAL; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MENTAL DISORDERS; OBSERVATION; OUTCOME ASSESSMENT (HEALTH CARE); PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 82155192831     PISSN: 10498931     EISSN: 15570657     Source Type: Journal    
DOI: 10.1002/mpr.356     Document Type: Article

References (61)

1. Bakker M.K., Kerstjens-Frederikse W.S., Buys C.H.C.M., De Walle H.E.K., De Jong-van Den Berg L.T.W. (2010) First-trimester use of paroxetine and congenital heart defects: A population-based case-control study. Birth Defects Research. Part A, Clinical and Molecular Teratology, 88(2), 94-100. DOI: 10.1002/bdra.20641
2. Bennett H.A., Einarson A., Taddio A., Koren G., Einarson T.R. (2004) Prevalence of depression during pregnancy: Systematic review. Obstetrics and Gynecology, 103(4), 698-709. DOI: 10.1097/01.AOG.0000116689.75396.5f
3. Berard A., Ramos E., Rey E., Blais L., St-Andre M., Oraichi D. (2007) First trimester exposure to paroxetine and risk of cardiac malformations in infants: The importance of dosage. Birth Defects Research. Part B, Developmental and Reproductive Toxicology, 80(1), 18-27. DOI: 10.1002/bdrb.20099
4. Boucher N., Bairam A., BeaulacBaillargeon L. (2008) A new look at the neonate's clinical presentation after in utero exposure to antidepressants in late pregnancy. Journal of Clinical Psychopharmacology, 28(3), 334-339. DOI: 10.1097/JCP.0b013e318173aa2e
5. Chabrol H., Teissedre F., Armitage J., Danel M., Walburg V. (2004) Acceptability of psychotherapy and antidepressants for postnatal depression among newly delivered mothers. Journal of Reproductive and Infant Psychology, 22(1), 5-12. DOI: 10.1080/02646830310001643094
6. Cohen L.S., Altshuler L.L., Harlow B.L., Nonacs R., Newport D.J., Viguera A.C., et al. (2006) Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment [corrected] [published erratum appears in JAMA 296(2): 170]. JAMA: The Journal of the American Medical Association, 295(5), 499-507. DOI: 10.1001/jama.295.5.499
7. Costei A.M., Kozer E., Ho T., Ito S., Koren G. (2002) Perinatal outcome following third trimester exposure to paroxetine. Archives of Pediatrics & Adolescent Medicine, 156(11), 1129-1132.
8. Davis R.L., Rubanowice D., McPhillips H., Raebel M.A., Andrade S.E., Smith D., Yood M.U., Platt R., H.M.O. Research Network Center for Education, Research in Therapeutics. (2007) Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy [see comment]. Pharmacoepidemiology and Drug Safety, 16(10), 1086-1094. DOI: 10.1002/pds.1462
9. Dennis C.L. (2004a) Preventing postpartum depression part I: A review of biological interventions. Canadian Journal of Psychiatry [Revue Canadienne De Psychiatrie], 49(7), 467-475.
10. Dennis C.L. (2004b) Preventing postpartum depression part II: A critical review of nonbiological interventions. Canadian Journal of Psychiatry [Revue Canadienne De Psychiatrie], 49(8), 526-538.
11. Dennis C.L. (2004c) Treatment of postpartum depression, part 2: A critical review of nonbiological interventions. The Journal of Clinical Psychiatry, 65(9), 1252-1265.
12. Dennis C.L., Stewart D.E. (2004) Treatment of postpartum depression, part 1: A critical review of biological interventions. The Journal of Clinical Psychiatry, 65(9), 1242-1251.
13. Dietz P.M., Williams S.B., Callaghan W.M., Bachman D.J., Whitlock E.P., Hornbrook M.C. (2007) Clinically identified maternal depression before, during, and after pregnancies ending in live births. The American Journal of Psychiatry, 164(10), 1515-1520. DOI: 10.1176/appi.ajp.2007.06111893
14. Downs S.H., Black N. (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. Journal of Epidemiology and Community Health, 52(6), 377-384. DOI:10.1136/jech.52.6.377
15. Egger M., Schneider M., Smith G.D. (1998) Meta-analysis: Suprious precision? Meta-analysis of observational studies. British Medical Journal, 316(7125), 140.
16. Einarson A., Choi J., Einarson T.R., Koren G. (2010) Adverse effects of antidepressant use in pregnancy: An evaluation of fetal growth and preterm birth. Depression and Anxiety, 27(1), 35-38. DOI: 10.1002/da.20598
17. Einarson A., Schachtschneider A.K., Halil R., Bollano E., Koren G. (2005) SSRI'S and other antidepressant use during pregnancy and potential neonatal adverse effects: Impact of a public health advisory and subsequent reports in the news media. BMC Pregnancy and Childbirth, 5, 11. DOI: 10.1186/1471-2393-5-11
18. Evidence-based Medicine Working Group. (1992) Evidence-based medicine: A new approach to teaching the practice of medicine. JAMA: The Journal of the American Medical Association, 268(17), 2420-2425. DOI: 10.1001/jama.1992.03490170092032
19. Ferreira E., Carceller A.M., Agogue C., Martin B.Z., St-Andre M., Francoeur D., et al. (2007) Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics, 119(1), 52-59. DOI: 10.1542/peds.2006-2133
20. Galbally M., Lewis A.J., Lum J., Buist A. (2009) Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: Prospective controlled study. The Australian and New Zealand Journal of Psychiatry, 43(9), 846-854.
21. Gaynes B.N., Gavin N., Meltzer-Brody S., Lohr K.N., Swinson T., Gartlehner G., et al. (2005) Perinatal Depression: Prevalence, Screening Accuracy, and Screening Outcomes. Evidence Report/Technology Assessment No. 119 (prepared by the RTI-University of North Carolina Evidence-based Practice Center, under contract no. 290-02-0016), No. AHRQ Publication No. 05-E006-2. Rockville, MD, Agency for Healthcare Research and Quality.
22. Gjerdingen D. (2003) The effectiveness of various postpartum depression treatments and the impact of antidepressant drugs on nursing infants. The Journal of the American Board of Family Practice/American Board of Family Practice, 16(5), 372-382. DOI: 10.3122/jabfm.16.5.372
23. Gupta M. (2009) Ethics and evidence in psychiatric practice. Perspectives in Biology and Medicine, 52(2), 276-288. DOI: 10.1353/pbm.0.0081
24. Guyatt G.H., Oxman A.D., Vist G.E., Kunz R., Falck-Ytter Y., Alonso-Coello P., et al. (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. British Medical Journal, 336, 924-926.
25. Judd L.L., Akiskal H.S., Maser J.D., Zeller P.J., Endicott J., Coryell W., et al. (1998) A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Archives of General Psychiatry, 55(8), 694-700.
26. Kallen B.A., Otterblad O.P. (2007) Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Research, 79(4), 301-308. DOI: 10.1002/bdra.20327
27. Khan K.S., ter Riet G., Glanville J., Sowden A.J., Kleijnen J. (2001) Undertaking Systematic Reviews of Research on Effectiveness CRD's Guidance for those Carrying Out or Commissioning Reviews, CRD Report Number 4 (2nd ed.). York, NHS Centre for Reviews and Dissemination, University of York.
28. Kornum J.B., Nielsen R.B., Pedersen L., Mortensen P.B., Norgaard M. (2010) Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: Updated analysis. Clinical Epidemiology, 2(1), 29-36. DOI: 10.2147/CLEP.S9256
29. Laine K., Heikkinen T., Ekblad U., Kero P. (2003) Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Archives of General Psychiatry, 60(7), 720-726.
30. Levinson-Castiel R., Merlob P., Linder N., Sirota L., Klinger G. (2006) Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Archives of Pediatrics & Adolescent Medicine, 160(2), 173-176.
31. Lewis A.J., Galbally M., Opie G., Buist A. (2010) Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication. The Australian and New Zealand Journal of Psychiatry, 44(5), 482-487. DOI: 10.3109/00048670903559593
32. Mallen C., Peat G., Croft P. (2006) Quality assessment of observational studies is not commonplace in systematic reviews. Journal of Clinical Epidemiology, 59(8), 765-769. DOI: 10.1016/j.jclinepi.2005.12.010
33. Mann C.J. (2003) Observational research methods. research design II: Cohort, cross sectional, and case-control studies. EMJ: Emergency Medicine Journal, 20(1), 54-60. DOI: 10.1136/emj.20.1.54
34. Mann R., Gilbody S., Adamson J. (2010) Prevalence and incidence of postnatal depression: What can systematic reviews tell us? Archives of Women's Mental Health, 13(4):295-305.
35. Meldrum M.L. (2000) A brief history of the randomized controlled trial. From oranges and lemons to the gold standard. Hematology/Oncology Clinics of North America, 14(4), 745-760, vii.
36. Merlob P., Birk E., Sirota L., Linder N., Berant M., Stahl B., et al. (2009) Are selective serotonin reuptake inhibitors cardiac teratogens? Echocardiographic screening of newborns with persistent heart murmur. Birth Defects Research, 85(10), 837-841. DOI: 10.1002/bdra.20615
37. Michaud C.M., Murray C.J., Bloom B.R. (2001) Burden of disease - implications for future research. JAMA: The Journal of the American Medical Association, 285(5), 535-539. DOI: 10.1001/jama.285.5.535
38. Nonacs R., Cohen L.S. (2000) Postpartum psychiatric syndromes. In Sadock B., Sadock V. (eds) Comprehensive Textbook of Psychiatry (7th ed.), pp. 1276-1283. Philadelphia, PA, Lippincott Williams and Wilkins.
39. Nordeng H., Lindemann R., Perminov K.V., Reikvam A. (2001) Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors. Acta Paediatrica, 90(3), 288-291. DOI: 10.1111/j.1651-2227.2001.tb00306.x
40. O'Hara M.W., Swain A.M. (1996) Rates and risk of postpartum depression - a meta-analysis. International Review of Psychiatry, 8(1), 37-54.
41. Oberlander T.F., Eckstein G.R., Fitzgerald C., Ellwood A.L., Misri S., Rurak D., et al. (2002) Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response. Pediatric Research, 51(4), 443-453.
42. Oberlander T.F., Reebye P., Misri S., Papsdorf M., Kim J., Grunau R.E. (2007) Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. Archives of Pediatrics & Adolescent Medicine, 161(1), 22-29.
43. Oberlander T.F., Warburton W., Misri S., Aghajanian J., Hertzman C. (2008) Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: Population-based study. The British Journal of Psychiatry, 192(5), 338-343. DOI: 10.1192/bjp.bp.107.037101
44. Orr S.T., Miller C.A. (1995) Maternal depressive symptoms and the risk of poor pregnancy outcome. Review of the literature and preliminary findings. Epidemiologic Reviews, 17(1), 165-171.
45. Paris J. (2000) Canadian psychiatry across five decades: From clinical inference to evidence-based practice. Canadian Journal of Psychiatry, 45, 34-39.
46. Pastuszak A., SchickBoschetto B., Zuber C., Feldkamp M., Pinelli M., Sihn S., et al. (1993) Pregnancy outcome following first-trimester exposure to fluoxetine (prozac). JAMA: The Journal of the American Medical Association, 269(17), 2246-2248. DOI: 10.1001/jama.1993.03500170076037
47. Pedersen L.H., Henriksen T.B., Vestergaard M., Olsen J., Bech B.H. (2009) Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: Population based cohort study. British Medical Journal, 339(7723), 735.
48. Ramos E., Oraichi D., Rey E., Blais L., Berard A. (2007) Prevalence and predictors of antidepressant use in a cohort of pregnant women. BJOG: An International Journal of Obstetrics and Gynaecology, 114(9), 1055-1064. DOI: 10.1111/j.1471-0528.2007.01387.x
49. Rampono J., Simmer K., Ilett K.F., Hackett L.P., Doherty D.A., Elliot R., et al. (2009) Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry, 42(3), 95-100.
50. Reis M., Kallen B. (2010) Delivery outcome after maternal use of antidepressant drugs in pregnancy: An update using Swedish data. Psychological Medicine, 40(10), 1723-1733. DOI: 10.1017/S0033291709992194
51. Sharma V. (2002) Pharmacotherapy of postpartum depression. Expert Opinion on Pharmacotherapy, 3(10), 1421-1431. DOI: 10.1517/14656566.3.10.1421
52. Steer R.A., Scholl T.O., Hediger M.L., Fischer R.L. (1992) Self-reported depression and negative pregnancy outcomes. Journal of Clinical Epidemiology, 45(10), 1093-1099.
53. Stiskal J.A., Kulin N., Koren G., Ho T., Ito S. (2001) Neonatal paroxetine withdrawal syndrome. Archives of Disease in Childhood. Fetal and Neonatal Edition, 84(2), F134-F135.
54. Straus S.E., Ball C., Balcombe N., Sheldon J., McAlister F.A. (2005) Teaching evidence-based medicine skills can change practice in a community hospital. Journal of General Internal Medicine, 20(4), 340-343. DOI: 10.1111/j.1525-1497.2005.04045.x
55. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. (2000) Meta-analysis of observational studies in epidemiology: A proposal for reporting. meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA: The Journal of the American Medical Association, 283(15), 2008-2012. DOI: 10.1001/jama.283.15.2008
56. Suri R., Altshuler L., Hellemann G., Burt V.K., Aquino A., Mintz J. (2007) Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. The American Journal of Psychiatry, 164(8), 1206-1213. DOI: 10.1176/appi.ajp.2007.06071172
57. Von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., Vandenbroucke J.P., et al. (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet, 370(9596), 1453-1457. DOI: 10.1016/S0140-6736(07)61602-X
58. Wells G.A., Shea B., O'Connell D., Petersen J., Welch V., Losos M., et al. (2003) The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-analyses. Ottawa, Department of Epidemiology and Community Medicine, University of Ottawa.
59. Wen S.W., Yang Q., Garner P., Fraser W., Olatunbosun O., Nimrod C., et al. (2006) Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. American Journal of Obstetrics and Gynecology, 194(4), 961-966. DOI: 10.1016/j.ajog.2006.02.019
60. Zuckerman B., Amaro H., Bauchner H., Cabral H. (1989) Depressive symptoms during pregnancy: Relationship to poor health behaviors. American Journal of Obstetrics and Gynecology, 160(5 Pt 1), 1107-1111.
61. Zuckerman B., Bauchner H., Parker S., Cabral H. (1990) Maternal depressive symptoms during pregnancy, and newborn irritability. Journal of Developmental and Behavioral Pediatrics, 11(4), 190-194.